Cited by 88Dementia and Cognitive Impairment ResearchHealth disparities and outcomesMental Health Treatment and Access

Inequalities in receipt of mental and physical healthcare in people with dementia in the UK

Open access
Cooper, Claudia, Lodwick, Rebecca, Walters, Kate, Raine, Rosalind, Manthorpe, Jill, Iliffe, Steve, Petersen, Irene·2016·Age and Ageing

Abstract

Background: UK Dementia Strategies prioritise fair access to mental and physical healthcare. We investigated whether there are inequalities by deprivation or gender in healthcare received by people with dementia, and compared healthcare received by people with and without dementia. Methods: we investigated primary care records of 68,061 community dwelling dementia patients and 259,337 people without dementia (2002-13). We tested hypotheses that people with dementia from more deprived areas, and who are women receive more psychotropic medication, fewer surgery consultations, are less likely to receive annual blood pressure, weight monitoring and an annual review, compared with those from less deprived areas and men. Results: only half of people with dementia received a documented annual review. Deprivation was not associated with healthcare received. Compared to men with dementia, women with dementia had lower rates of surgery consultations (adjusted incidence rate ratio (IRR) 0.90, 95% CI 0.90-0.91), of annual blood pressure monitoring (adjusted IRR 0.96, 95% CI 0.95-0.97) and of annual weight monitoring (adjusted IRR 0.91, 95% CI 0.90-0.93). Men with dementia were less likely to be taking psychotropic medication than women with dementia. People with dementia had fewer surgery consultations and were less likely to have their weight and blood pressure monitored at least annually, compared to the non-dementia group. Conclusions: people with dementia, in particular women, appear to receive less primary healthcare, but take more psychotropic medication that may negatively impact their physical health. Reducing these inequalities and improving access of people with dementia to preventative healthcare could improve the health of people with dementia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ageing/afw208

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An RCT reporting 6-year follow-up after the eight-session STrAtegies for RelaTives intervention found continuing effectiveness for depressive symptoms in carers (adjusted MD −2.00; 95% CI −3.4 to −0.6) and risk of case-level depression, with patient-related cost approximately 3 times lower than those who did not receive the intervention (median £5759 vs £16 964 in the final year; p=0.07).

    “An RCT233 reporting 6-year follow-up after the eight session STrAtegies for RelaTives intervention—manual-based coping intervention delivered by supervised psychology graduates—found continuing effectiveness for depressive symptoms in carers (adjusted MD −2·00; 95% CI −3·4 to −0·6) and risk of case-level depression, with patient-related cost being approximately 3 times lower than those who did not”

    From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [233]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 30

  1. [1]Poblador-Plou B, Calderon-Larranaga A, Marta-Moreno J et al Comorbidity of dementia: a cross-sectional study of primary care older patients. BMC Psychiatry 2014; 14:84. PMC3994526 24645776
  2. [2]Laitinen ML, Bell JS, Lavikainen P, Lonnroos E, Sulkava R, Hartikainen S Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland. Int Psychogeriatr 2011; 23(10): 1623– 31. 21867581
  3. [3]Schulze J, Glaeske G, van den Bussche H et al Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf 2013; 22(12): 1308– 16. 24123506
  4. [4]Barnes TR, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry 2012; 201(3): 221– 6. 22790679
  5. [5]Luppa M Luck T, Braehler E, Koenig HH, Riedel-Heller SG Prediction of institutionalisation in dementia - A systematic review. Dementia and geriatric cognitive disorders 2008; 26(1): 65– 78 18617737
  6. [6]Bordier L, Doucet J, Boudet J, Bauduceau B Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab 2014; 40(5): 331– 7. 24703603
  7. [7]Ballard C, Margallo-Lana M, Juszczak E et al Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. Br Med J 2005; 330(7496): 874– 7. 15722369 PMC556156
  8. [8]Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbaek G Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. Am J Geriatr Psychiatry 2014 Apr; 22(4): 321– 31. 24016844
  9. [9]Sterke CS, van Beeck EF, van d Velde N et al New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol 2012; 52(6): 947– 55. 21628599
  10. [10]Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent. Int J Geriatr Psychiatry 2007; 22(12): 1194– 200. 17407168
  11. [11]Rosenberg PB, Mielke MM, Han D et al The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. Int J Geriatr Psychiatry 2012 Dec; 27(12): 1248– 57. 22374884 PMC3448859
  12. [12]Medicines and Healthcare products Regulatory Agency CoHM Antipsychotics: use in elderly people with dementia. Drug Saf Update 2009; 2: 8.
  13. [14]Martinez C, Jones RW, Rietbrock S Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open 2013; 3(1):e002080. PMC3549220 23299113
  14. [15]Guthrie B, Clark SA, Reynish EL, McCowan C, Morales DR Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001–2011. PLoS One 2013; 8(7): e68976. 23874832 PMC3714253
  15. [16]McIlroy G, Thomas SK, Coleman JJ Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing. J Public Health (Oxf) 2015; 37(2): 346– 52. 24681910 PMC5942530
  16. [17]Hart JT Inverse care law. Lancet 1971; 1(7696): 405– &. 4100731
  17. [18]Cooper C, Lodwick R, Walters K et al Observational cohort study: deprivation and access to anti-dementia drugs in the UK. Age Ageing 2016; 45(1): 148– 54. 26582758 PMC4711654
  18. [19]Booth N What are the Read Codes. Health Libr Rev 1994; 11: 177– 82. 10139676
  19. [20]Horsfall L, Walters K, Petersen I Identifying periods of acceptable computer usage in primary care research databases. Pharmacoepidemiol Drug Saf 2013; 22(1): 64– 9. 23124958
  20. [21]Maguire A, Blak BT, Thompson M The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009; 18(1): 76– 83. 19065600
  21. [22]Dave S, Petersen I Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009; 18(8): 704– 7. 19455565
  22. [25]Brilleman SL, Salisbury C Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract 2013; 30(2): 172– 8. 23045354 PMC3604888
  23. [26]Shah SM, Carey IM, Harris T, DeWilde S, Cook DG Antipsychotic prescribing to older people living in care homes and the community in England and Wales. Int J Geriatr Psychiatry 2011; 26(4): 423– 34. 20878663
  24. [27]Livingston G, Kelly L, Lewis-Holmes E et al A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia. Health Technol Assess 2014; 18(39): 1– vi. PMC4781145 24947468
  25. [28]McBride D, Hardoon S, Walters K, Gilmour S, Raine R Explaining variation in referral from primary to secondary care: cohort study. Br Med J 2010: 341. PMC2995017 21118873
  26. [29]Collerton J, Davies K, Jagger C et al Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009; 339: b4904. 20028777 PMC2797051
  27. [31]Cooper C, Bebbington P et al The treatment of common mental disorders across age groups: Results from the 2007 adult psychiatric morbidity survey. J Affect Disord 2010; 127(1–3): 96– 101. 20466432
  28. [32]Marston L, Nazareth I, Petersen I, Walters K, Osborn DP Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open 2014; 4(12): e006135. PMC4281533 25524544
  29. [33]Feldman L, Wilcock J, Thuné-Boyle I, Iliffe S Explaining the effects of symptom attribution by carers on help-seeking for individuals living with dementia. Dementia 1471301215593185, first published on June 30, 2015. doi:10.1177/1471301215593185. 26130674 · DOI
  30. [34]McCann M, Donnelly M, O'Reilly D Living arrangements, relationship to people in the household and admission to care homes for older people. Age Ageing 2011 May; 40(3): 358– 63. 21427114

Cited by

Sorted by citations

Authors
Cooper, C., Lodwick, R., Walters, K., Raine, R., Manthorpe, J., Iliffe, S., & Petersen, I.
Affiliations
  • Camden and Islington NHS Foundation Trust (GB)
  • University College London (GB)
  • King's College London (GB)
Corresponding author
Cooper, Claudia
Venue
Age and Ageing
Published
2016-12-04
Volume
46
Issue
3
Pages
393-400
ISSN
  • 0002-0729 (ISSN-L)
  • 1468-2834
OpenAlex
W2557376713
Cited by
88
References
0
Citations by year
2026: 2 · 2025: 8 · 2024: 8 · 2023: 17 · 2022: 8 · 2021: 18 · 2020: 15 · 2019: 6 · 2018: 4 · 2017: 2
FWCI
3.55
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Age and Ageing (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by-nc)
  • UCL Discovery (University College London) (submittedVersion)
Funders
The Dunhill Medical Trust (R296/0513)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Health › Health disparities and outcomes
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
dementia, health care disparities, socioeconomic deprivation, gender differences, psychotropic drugs, primary care, annual review, blood pressure monitoring, weight monitoring, preventive medicine, women with dementia
MeSH terms
Aged, Aged, 80 and over, Anthropometry, Blood Pressure Determination, Body Weight, Dementia, Female, United Kingdom, Health Services for the Aged, Humans, Male, Mental Health Services, Middle Aged, Primary Health Care, Psychotropic Drugs, Referral and Consultation, Sex Factors, Socioeconomic Factors, Surgical Procedures, Operative, Geriatric Assessment, Delivery of Health Care, Integrated, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review